SourceBio International PLC in earnings enhancing acquisition
SourceBio International PLC (AIM:SBI) is to acquire LDPath, a London-based provider of digital pathology testing services. The initial consideration will be...
Stay updated with breaking news from Cellular Pathology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SourceBio International PLC (AIM:SBI) is to acquire LDPath, a London-based provider of digital pathology testing services. The initial consideration will be...
FEW have embraced the spirit of fundraising and voluntarism as much as Rory Evans.
In this interview, News-Medical talks to Dr. Mauro D’Amato about how there could be clues about the regularity of bowel movements within our genes.
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at ‘intermediate risk’ who can safely avoid